• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6199919
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/25/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that reproducible and discordant vitros cov2igg results were obtained from a single patient sample when tested using vitros cov2igg lot 0160 on a vitros eciq immunodiagnostic system.The results were discordant when compared to non-reactive vitros cov2tot results from the same patient sample.A definitive cause of the discordant reactive vitros cov2igg results was not determined.The patient that produced the discordant vitros results was drawn from the physician who was performing a study on healthy blood donors using the vitros covid assays.The physician was healthy and had no history of symptoms associated with a covid-19 infection.There were no options for pcr testing or alternate antibody testing to assist with investigation.Based on the patient history it was concluded that the cov2igg was a false reactive result.A vitros cov2igg lot 0160 reagent issue is an unlikely contributor to the event, as acceptable results were obtained on the day of initial testing and subsequent patient results were similar to the initial results.Additionally, ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros cov2igg reagent lot 0160.Unexpected instrument performance is not a likely contributor to the events.However, it cannot be entirely ruled out as a contributing factor as precision testing to assess instrument performance was not performed by the customer when requested.Improper pre-analytical sample handling was a potential contributor to this event.It is possible that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.A heterophilic or non-specific antibody interferent was ruled out as the cause of the discordance between vitros cov2tot and vitros cov2igg results, as the results obtained using the sample treated with a nabt and hbt were concordant (cov2igg reactive) with results from untreated samples.
 
Event Description
A customer contacted the ortho clinical diagnostics (ortho) technical solutions centre (tsc) to report discordant reactive vitros anti- sars-cov-2 igg (cov2igg) results obtained from a single patient sample when tested on a vitros eciq immunodiagnostic system.The vitros cov2igg results were believed to be discordant based on non-reactive vitros anti- sars-cov-2 total (cov2tot) results from the same patient sample.Vitros cov2igg result of 2.65, 2.74, and 2.45 s/c (reactive) versus the expected result of non-reactive.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The vitros cov2igg results were not reported from the laboratory.There was no allegation of patient harm as a result of this event.This report corresponds to ortho clinical diagnostics inc.Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key10302102
MDR Text Key200963029
Report Number3007111389-2020-00074
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Physician
Type of Report Initial
Report Date 07/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/18/2020
Device Catalogue Number6199919
Device Lot Number0160
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/27/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/21/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-